Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc., 13928 [2020-04832]
Download as PDF
<![CDATA[
13928
Federal Register / Vol. 85, No. 47 / Tuesday, March 10, 2020 / Notices
Drug Enforcement Administration
[Docket No. DEA–579]
Bulk Manufacturer of Controlled
Substances Application: Sigma Aldrich
Research
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 11, 2020.
DATES:
DEPARTMENT OF JUSTICE
Notice of application.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
ADDRESSES:
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on December 13, 2019,
Sigma Aldrich Research, Biochemicals,
Inc., 400–600 Summit Drive, Burlington,
Massachusetts 01803 applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
Controlled substance
Drug code
Cathinone ........................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
Alpha-methyltryptamine ...................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Morphine ..........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Remifentanil .....................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
for distribution to its customers.
Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–04831 Filed 3–9–20; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
khammond on DSKJM1Z7X2PROD with NOTICES
[Docket No. DEA–583]
Bulk Manufacturer of Controlled
Substances Application: Siemens
Healthcare Diagnostics Inc.
ACTION:
Notice of application.
VerDate Sep<11>2014
17:20 Mar 09, 2020
Jkt 250001
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 11, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on December 10, 2019,
Siemens Healthcare Diagnostics Inc.,
100 GBC Drive, Mailstop 514, Newark,
Delaware 19702–2461 applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
DATES:
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Controlled substance
1235
1248
7315
7370
7405
7432
7435
7439
7493
7517
7535
7540
9200
9313
9634
1100
7379
7471
9041
9050
9180
9220
9230
9250
9300
9333
9648
9668
9739
9740
9743
9801
Drug
code
Ecgonine ...................
9180
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Schedule
II
The company plans to produce the
listed controlled substance in bulk to be
used in the manufacture of DEA exempt
products.
Dated: February 11, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–04832 Filed 3–9–20; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\10MRN1.SGM
10MRN1
]]>Agencies
[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Page 13928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04832]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-583]
Bulk Manufacturer of Controlled Substances Application: Siemens
Healthcare Diagnostics Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 11, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on December 10, 2019, Siemens Healthcare Diagnostics
Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702-2461 applied
to be registered as a bulk manufacturer of the following basic classes
of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Ecgonine.............................. 9180 II
------------------------------------------------------------------------
The company plans to produce the listed controlled substance in
bulk to be used in the manufacture of DEA exempt products.
Dated: February 11, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04832 Filed 3-9-20; 8:45 am]
BILLING CODE 4410-09-P
